Pipobroman

From Wikipedia, the free encyclopedia - View original article

Pipobroman
Pipobroman.svg
Systematic (IUPAC) name
3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
Clinical data
Trade namesVercite, Vercyte
AHFS/Drugs.comInternational Drug Names
Legal status?
Identifiers
CAS number54-91-1
ATC codeL01AX02
PubChemCID 4842
DrugBankDB00236
ChemSpider4676 YesY
UNII6Q99RDT97R YesY
KEGGD00467 YesY
ChEMBLCHEMBL1585 YesY
Chemical data
FormulaC10H16Br2N2O2 
Mol. mass356.054 g/mol
 YesY (what is this?)  (verify)
 
Jump to: navigation, search
Pipobroman
Pipobroman.svg
Systematic (IUPAC) name
3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
Clinical data
Trade namesVercite, Vercyte
AHFS/Drugs.comInternational Drug Names
Legal status?
Identifiers
CAS number54-91-1
ATC codeL01AX02
PubChemCID 4842
DrugBankDB00236
ChemSpider4676 YesY
UNII6Q99RDT97R YesY
KEGGD00467 YesY
ChEMBLCHEMBL1585 YesY
Chemical data
FormulaC10H16Br2N2O2 
Mol. mass356.054 g/mol
 YesY (what is this?)  (verify)

Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.[1] It is marketed by Abbott Laboratories.[2]

References[edit]

  1. ^ Passamonti, F.; Lazzarino, M. (2003). "Treatment of Polycythemia Vera and Essential Thrombocythemia: The Role of Pipobroman". Leukemia & Lymphoma 44 (9): 1483–1488. doi:10.3109/10428190309178768. PMID 14565648.  edit
  2. ^ Drugs.com: Pipobroman